Cannabimovone (CBM) beneficial cannabinoid for diabetes and eating disorders

CBM has the potential to help many people with metabolic disorders, diabetes and eating problems.
April 22, 2020

This post is also available in: Español

Today on the radar of new cannabinoids we have cannabimovone  (CBM),  a cannabinoid that according to research is found in various cannabis genetics and that could be a revolutionary compound to analyze the way in which the human body behaves against externals or internal agents.

A new study published in MDPI earlier this year shows that CBM used in clinical trials has the potential to help many people with metabolic disorders, diabetes and eating problems.

CBM contains a known active agent derived from a genetic known as "Carmagnola"” which according to some experts could be the future of medical research with CBD.

An important discovery

According to the study, from a technical point of view, this CBM cannabinoid behaves similarly to CBD or THC. However, a new important focus of study has been found. According to this new research, it was shown that this cannabinoid adheres to important body receptors such as PPARα and PPAR,γ, vital in neuronal  functioning.

For those who do not family with these concepts, it has been shown that PPARα and PPARγ are responsible forthe ordering of our genetic material, as well as the creation of new key cells within our organisms.

These include the kidneys, colon, heart, and liver. These receptors are responsible for hormonal, metabolic regulation and are directly related to the carcinogenic prevention of certain cancers according to the scientific information available.

Researchers demonstrated by using the models in the lab that CBM has the potential to easily adhere to these receptors and partially activate them. Therefore, if the research continues it could be said that this cannabinoid would serve to treat diabetes or insulin resistance.

Read the full investigation at the link: https://www.ncbi.nlm.nih.gov/pubmed/32138197

This post is also available in: Español

Escrito por: Daniel Gomez
Publicado en la revista 
SíGUENOS EN INSTAGRAM COMO @MCNGLOBAL

#MCNVirales: 😅😅😅 ...

Con 82 votos a favor y 18 en contra más 7 abstenciones, el Senado de la República Mexicana aprobó en lo general el dictamen para despenalizar y regular el consumo personal lúdico del cannabis en todo los Estados. 🇲🇽 Link en Bio ...

#CasoMarioCerdas: Las pruebas que se utilizaron para encarcelar al abogado son ilegales y espurias, determinó uno de los jueces, Alberto García. Su abogado José Miguel Villalobos se encuentra preparando la apelación para el fallo de los tribunales. ...

Algo no anda bien con esta prohibición. 😤😤☢️☢️ #pesticidefree #cannabiscura #hempheals ...

Estudios han demostrado que este tipo de tratamientos sirven en este tipo de pacientes a reducir la ansiedad y la depresión. 🍄 #psicotherapy . #Psilocibina . Link en BIO ...

Lo más reciente en MCN

También te puede interesar

November 24, 2020
Cannabis legalization: the only social justice left by the U.S. presidential election

This post is also available in: EspañolMississippi, New Jersey, Arizona, Montana, South Dakotaare on the […]

Ver Artículo
November 24, 2020
Antidepressive, ansiolitic and spiritual well-being promoter: the effects of magic mushrooms

Psylocibin mushrooms: 3 conditions that can help treat

Ver Artículo
November 24, 2020
Oregon legalizes psilocybin for medical purposes

First State to Legalize magic mushroom therapy

Ver Artículo
November 24, 2020
Chicago: Cannabis taxes saved 250 jobs

Sales produced more than $800 million in taxes in 2020

Ver Artículo
Copyright Zegreenlab S.A. Todos los derechos reservados © 2020. Hecho en Costa Rica.
Diseño & Desarrollo por Dbugger Studio
magnifiercrossmenucross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram